Mersana Therapeutics Ownership 2024 | Who Owns Mersana Therapeutics Now?
Institutional Ownership
94.03%
Insider Ownership
1.35%
Retail Ownership
4.61%
Institutional Holders
124.00
Mersana Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | 15.95% | 1.19% | 19,364,688 | - | - | 38,923,023 | Jun 30, 2024 |
| VR ADVISER, LLC | 9.33% | 1.45% | 11,328,000 | - | - | 22,769,280 | Jun 30, 2024 |
| NEXTECH INVEST LTD. | 7.85% | 3.22% | 9,526,146 | 5,669,825 | 147.03% | 19,147,553 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 7.13% | 1.91% | 8,663,673 | - | - | 17,413,983 | Jun 30, 2024 |
| BLACKROCK INC. | 6.90% | 0.00% | 8,383,910 | 288,181 | 3.56% | 16,851,658 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.52% | 0.00% | 6,702,521 | 428,151 | 6.82% | 13,472,066 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 2.51% | 0.18% | 3,046,782 | - | - | 6,124,032 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 2.45% | 0.04% | 2,976,918 | 1,968,260 | 195.14% | 5,983,605 | Jun 30, 2024 |
| STATE STREET CORP | 2.21% | 0.00% | 2,682,055 | -2,815,388 | -51.21% | 5,390,931,000 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.14% | 0.30% | 2,600,000 | - | - | 5,226,000 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.06% | 1.19% | 2,500,585 | -468,213 | -15.77% | 5,026,176 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.05% | 0.00% | 2,493,423 | 135,202 | 5.73% | 5,012,423 | Jun 30, 2024 |
| MORGAN STANLEY | 1.87% | 0.00% | 2,272,594 | -670,083 | -22.77% | 4,567,914 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.63% | 0.00% | 1,976,899 | 549,559 | 38.50% | 3,973,567 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 1.37% | 2.82% | 1,663,000 | -501,628 | -23.17% | 3,342,630 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.30% | 0.00% | 1,576,000 | -9,263 | -0.58% | 3,167,760 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.21% | 0.03% | 1,467,311 | -1,467,311 | -50.00% | 2,949,295 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.21% | 0.00% | 1,465,580 | 242,957 | 19.87% | 2,945,815 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.19% | 0.00% | 1,448,219 | 20,400 | 1.43% | 2,910,920 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 1.07% | 0.59% | 1,305,000 | - | - | 2,623,050 | Jun 30, 2024 |
Mersana Therapeutics's largest institutional shareholder is ECOR1 CAPITAL, LLC, holding 15.95% of the company's total share outstanding, currently valued at $38.92M. The top 10 institutional shareholders own together 61.99% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NEXTECH INVEST LTD. | 7.85% | 3.22% | 9,526,146 | 5,669,825 | 147.03% | 19,147,553 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 1.37% | 2.82% | 1,663,000 | -501,628 | -23.17% | 3,342,630 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 7.13% | 1.91% | 8,663,673 | - | - | 17,413,983 | Jun 30, 2024 |
| VR ADVISER, LLC | 9.33% | 1.45% | 11,328,000 | - | - | 22,769,280 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 15.95% | 1.19% | 19,364,688 | - | - | 38,923,023 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.06% | 1.19% | 2,500,585 | -468,213 | -15.77% | 5,026,176 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 1.07% | 0.59% | 1,305,000 | - | - | 2,623,050 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 0.82% | 0.31% | 992,000 | -8,000 | -0.80% | 1,993,920 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.14% | 0.30% | 2,600,000 | - | - | 5,226,000 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.09% | 0.28% | 110,073 | 110,073 | 100.00% | 221,247 | Jun 30, 2024 |
| HEALTHINVEST PARTNERS AB | 0.15% | 0.23% | 184,900 | 84,900 | 84.90% | 371,649 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 2.51% | 0.18% | 3,046,782 | - | - | 6,124,032 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.63% | 0.18% | 767,000 | -233,000 | -23.30% | 1,541,670 | Jun 30, 2024 |
| AJOVISTA, LLC | 0.02% | 0.12% | 20,463 | 20,463 | 100.00% | 41,131 | Jun 30, 2024 |
| CLARIVEST ASSET MANAGEMENT LLC | 0.41% | 0.10% | 500,498 | 28,650 | 6.07% | 1,006,000 | Jun 30, 2024 |
| ATOM INVESTORS LP | 0.30% | 0.07% | 365,435 | -73,797 | -16.80% | 734,524 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.45% | 0.07% | 544,293 | 110,000 | 25.33% | 1,094,029 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 2.45% | 0.04% | 2,976,918 | 1,968,260 | 195.14% | 5,983,605 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.21% | 0.03% | 1,467,311 | -1,467,311 | -50.00% | 2,949,295 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 0.89% | 0.03% | 1,086,115 | - | - | 2,183,091 | Jun 30, 2024 |
The largest Mersana Therapeutics shareholder by % of total assets is NEXTECH INVEST LTD.. The company owns 9.53M shares of Mersana Therapeutics (MRSN), representing 3.22% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NEXTECH INVEST LTD. | 7.85% | 3.22% | 9,526,146 | 5,669,825 | 147.03% | 19,147,553 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 2.45% | 0.04% | 2,976,918 | 1,968,260 | 195.14% | 5,983,605 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.03% | 0.00% | 1,244,937 | 572,330 | 85.09% | 2,502,323 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.63% | 0.00% | 1,976,899 | 549,559 | 38.50% | 3,973,567 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.62% | 0.00% | 748,690 | 530,745 | 243.52% | 1,504,867 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.52% | 0.00% | 6,702,521 | 428,151 | 6.82% | 13,472,066 | Jun 30, 2024 |
| BLACKROCK INC. | 6.90% | 0.00% | 8,383,910 | 288,181 | 3.56% | 16,851,658 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.21% | 0.00% | 259,689 | 259,689 | 100.00% | 521,000 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.28% | 0.00% | 336,079 | 255,344 | 316.27% | 675,519 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.21% | 0.00% | 252,804 | 252,804 | 100.00% | 508,136 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.39% | 0.02% | 475,500 | 243,200 | 104.69% | 955,755 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.21% | 0.00% | 1,465,580 | 242,957 | 19.87% | 2,945,815 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.15% | 0.00% | 185,507 | 185,331 | 105301.70% | 372,869,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.14% | 0.00% | 176,029 | 137,596 | 358.02% | 353,818 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.05% | 0.00% | 2,493,423 | 135,202 | 5.73% | 5,012,423 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.09% | 0.28% | 110,073 | 110,073 | 100.00% | 221,247 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.45% | 0.07% | 544,293 | 110,000 | 25.33% | 1,094,029 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.09% | 0.00% | 107,174 | 107,174 | 100.00% | 215,000 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.11% | 0.00% | 138,722 | 105,209 | 313.93% | 279,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.10% | 0.02% | 121,432 | 87,893 | 262.06% | 244,078 | Jun 30, 2024 |
As of Jun 30 2024, Mersana Therapeutics's largest institutional buyer is NEXTECH INVEST LTD.. The company purchased 5.67M stocks of MRSN, valued at $19.15M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -3,655,998 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | 2.21% | 0.00% | 2,682,055 | -2,815,388 | -51.21% | 5,390,931,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.21% | 0.03% | 1,467,311 | -1,467,311 | -50.00% | 2,949,295 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.57% | 0.00% | 691,785 | -815,795 | -54.11% | 1,390,488 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | - | - | - | -801,437 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 1.87% | 0.00% | 2,272,594 | -670,083 | -22.77% | 4,567,914 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | - | - | - | -579,674 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.01% | 0.00% | 11,049 | -553,114 | -98.04% | 22,208 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 1.37% | 2.82% | 1,663,000 | -501,628 | -23.17% | 3,342,630 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.06% | 1.19% | 2,500,585 | -468,213 | -15.77% | 5,026,176 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.06% | 0.00% | 71,506 | -397,417 | -84.75% | 143,000 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | - | - | - | -368,434 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.40% | 0.00% | 485,593 | -324,286 | -40.04% | 976,042 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -310,000 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | 0.04% | - | 45,056 | -279,354 | -86.11% | 90,563 | Jun 30, 2024 |
| UBS GROUP AG | 0.03% | - | 34,983 | -254,684 | -87.92% | 70,316 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -239,143 | -100.00% | - | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.63% | 0.18% | 767,000 | -233,000 | -23.30% | 1,541,670 | Jun 30, 2024 |
| CANADA PENSION PLAN INVESTMENT BOARD | - | - | - | -204,900 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -129,515 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Mersana Therapeutics's biggest institutional seller is BALYASNY ASSET MANAGEMENT L.P.. The company sold -3.66M shares of MRSN, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.09% | 0.28% | 110,073 | 110,073 | 100.00% | 221,247 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.09% | 0.00% | 107,174 | 107,174 | 100.00% | 215,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 61,030 | 61,030 | 100.00% | 122,670 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 56,945 | 56,945 | 100.00% | 114,459 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.04% | 0.01% | 46,779 | 46,779 | 100.00% | 94,026 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.04% | 0.00% | 44,655 | 44,655 | 100.00% | 90,000 | Jun 30, 2024 |
| AJOVISTA, LLC | 0.02% | 0.12% | 20,463 | 20,463 | 100.00% | 41,131 | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | 0.01% | - | 11,300 | 11,300 | 100.00% | 22,713 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.01% | 0.00% | 10,200 | 10,200 | 100.00% | 20,502 | Jun 30, 2024 |
| STATE OF WYOMING | 0.01% | 0.00% | 9,158 | 9,158 | 100.00% | 18,408 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 1,911 | 1,911 | 100.00% | 3,812 | Jun 30, 2024 |
| OPTIVER HOLDING B.V. | 0.00% | - | 1,586 | 1,586 | 100.00% | 3,188 | Jun 30, 2024 |
| NORDWAND ADVISORS, LLC | 0.00% | 0.00% | 1,500 | 1,500 | 100.00% | 3,015 | Jun 30, 2024 |
| PICTON MAHONEY ASSET MANAGEMENT | 0.00% | - | 670 | 670 | 100.00% | 1,000 | Jun 30, 2024 |
Mersana Therapeutics's largest new institutional shareholder by number of shares is SUPERSTRING CAPITAL MANAGEMENT LP, purchased 110.07K shares, valued at $221.25K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -3,655,998 | -100.00% | - | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | - | - | - | -801,437 | -100.00% | - | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | - | - | - | -579,674 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | - | - | - | -368,434 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -310,000 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -239,143 | -100.00% | - | Jun 30, 2024 |
| CANADA PENSION PLAN INVESTMENT BOARD | - | - | - | -204,900 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -129,515 | -100.00% | - | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | - | - | - | -122,315 | -100.00% | - | Jun 30, 2024 |
| PROFUND ADVISORS LLC | - | - | - | -58,220 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -57,478 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -54,639 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -54,127 | -100.00% | - | Jun 30, 2024 |
| NEOS INVESTMENT MANAGEMENT LLC | - | - | - | -19,465 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -17,411 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -16,586 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -13,819 | -100.00% | - | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | - | - | - | -12,261 | -100.00% | - | Jun 30, 2024 |
| INCEPTIONR LLC | - | - | - | -11,188 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -4,677 | -100.00% | - | Jun 30, 2024 |
| PACER ADVISORS, INC. | - | - | - | -1,716 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -22 | -100.00% | - | Jun 30, 2024 |
Mersana Therapeutics's largest sold out institutional shareholder by shares sold is BALYASNY ASSET MANAGEMENT L.P., sold -3.66M shares, valued at -, as of undefined.
Mersana Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| HARTFORD HLS SERIES FUND II INC | 1.62% | 398,526 | - | - | Dec 31, 2023 |
| BlackRock Health Sciences Trust II | 0.56% | 1,472,110 | - | - | Mar 31, 2024 |
| Vanguard Montgomery Funds | 0.49% | 118,116 | 118,116 | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.34% | 162,383 | - | - | Mar 31, 2024 |
| HSBC FUNDS | 0.34% | 10,960 | - | - | Jan 31, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.33% | 23,652 | - | - | Sep 30, 2022 |
| PUTNAM GLOBAL HEALTH CARE FUND | 0.29% | 473,300 | - | - | Feb 29, 2024 |
| ALGER FUNDS | 0.28% | 266,755 | - | - | Jan 31, 2024 |
| BlackRock Health Sciences Trust | 0.23% | 57,179 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.22% | 533,177 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.14% | 74,304 | - | - | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.13% | 150,000 | - | - | Mar 28, 2024 |
| BRIDGEWAY FUNDS INC | 0.10% | 232,300 | - | - | Mar 28, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.09% | 282,545 | - | - | Mar 31, 2024 |
| MERIDIAN FUND INC | 0.09% | 209,924 | - | - | Mar 28, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.07% | 241,556 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.07% | 1,488 | - | - | Dec 31, 2023 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.06% | 184,500 | - | - | Mar 31, 2024 |
| ACAP Strategic Fund | 0.05% | 765,871 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.04% | 202,122 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.04% | 267,336 | 247,534 | 1250.05% | Aug 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 193,484 | -12,153 | -5.91% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 16,927 | 1,418 | 9.14% | Mar 31, 2024 |
| FORUM FUNDS II | 0.03% | 25,400 | 25,400 | - | Mar 31, 2024 |
| HARBOR FUNDS | 0.02% | 566,446 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 50,775 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.01% | 84,711 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 4,739,534 | -1,666,922 | -26.02% | Mar 31, 2024 |
| Harbor ETF Trust | 0.01% | 47,472 | 10,188 | 27.33% | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,994 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 308,072 | 13,667 | 4.64% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 89,837 | -94,553 | -51.28% | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 10,358 | - | - | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.01% | 84,339 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.01% | 85,123 | - | - | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 10,879 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 20,449 | - | - | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.01% | 108,140 | -119,696 | -52.54% | Mar 31, 2024 |
| ETF Series Solutions | 0.01% | 116,163 | 18,618 | 19.09% | Feb 29, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 240,451 | -304,005 | -55.84% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 967,370 | 80,010 | 9.02% | Feb 29, 2024 |
| BlackRock ETF Trust | 0.00% | 3,829 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 258,606 | - | - | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 330,563 | - | - | Jan 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 164,186 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 9,896 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 328,069 | - | - | Jan 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 13,514 | - | - | Dec 31, 2023 |
| MML SERIES INVESTMENT FUND | 0.00% | 25,743 | - | - | Dec 31, 2023 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 232,788 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 326,067 | - | - | Jan 31, 2024 |
| Meeder Funds | 0.00% | 9,756 | - | - | Mar 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 109,679 | 109,679 | - | Mar 31, 2024 |
| PUTNAM VARIABLE TRUST | 0.00% | 66,800 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 36,013 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 51,785 | -22,536 | -30.32% | Mar 31, 2024 |
| ProFunds | 0.00% | 19,565 | 18,632 | 1997.00% | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 8,249 | - | - | Mar 28, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 252,225 | - | - | Jan 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 36,562 | 25,211 | 222.10% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 17,670 | -1,453 | -7.60% | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 12,350 | - | - | Jan 31, 2024 |
| PRUDENTIAL SERIES FUND | 0.00% | 100,019 | - | - | Mar 28, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 6,000 | 5,900 | 5900.00% | Mar 31, 2024 |
| AMG FUNDS | 0.00% | 35,500 | - | - | Mar 28, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 36,527 | -9,506 | -20.65% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 25,696 | 368 | 1.45% | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 4,778 | - | - | Mar 28, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 3,054 | - | - | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 23,652 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 5,010 | -1,305 | -20.67% | Mar 31, 2024 |
| DEUTSCHE DWS SECURITIES TRUST | 0.00% | 30,581 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 491,841 | - | - | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 439 | - | - | Apr 30, 2021 |
| Virtus Investment Trust | 0.00% | 26,785 | - | - | Mar 28, 2024 |
| VANGUARD WORLD FUND | 0.00% | 185,371 | - | - | Feb 29, 2024 |
| AdvisorShares Trust | 0.00% | 2,988 | - | - | Mar 28, 2024 |
| JPMORGAN TRUST II | 0.00% | 670,598 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 39,700 | 5,100 | 14.74% | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 19,485 | - | - | Mar 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 43,866 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 135,043 | - | - | Jan 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 6,644 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 56,178 | -5,177 | -8.44% | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 3,040 | - | - | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 35,257 | - | - | Mar 28, 2024 |
| EQ ADVISORS TRUST | 0.00% | 350,380 | 49,658 | 16.51% | Mar 31, 2024 |
| COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.00% | 159,980 | - | - | Mar 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 2,400 | - | - | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 4,158,976 | -138,788 | -3.23% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 500,682 | 84,189 | 20.21% | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 1,003 | - | - | Mar 31, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 20,745 | - | - | Mar 28, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 916 | - | - | Dec 31, 2023 |
| GOLDMAN SACHS TRUST | 0.00% | 732,781 | - | - | Mar 31, 2024 |
| Victory Portfolios II | 0.00% | 8,894 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 902 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 14,515 | - | - | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 1,474 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 42,547 | 1,998 | 4.93% | Feb 29, 2024 |
Mersana Therapeutics's largest mutual fund holder by % of total assets is "HARTFORD HLS SERIES FUND II INC", owning 398.53K shares, compromising 1.62% of its total assets.
Mersana Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 124 | -3.13% |
| 31 Mar, 24 | 128 | 17.43% |
| 31 Dec, 23 | 109 | -18.05% |
| 30 Sep, 23 | 133 | -24.00% |
| 30 Jun, 23 | 175 | 4.79% |
| 31 Mar, 23 | 167 | 6.37% |
| 31 Dec, 22 | 157 | 5.37% |
| 30 Sep, 22 | 149 | 19.20% |
| 30 Jun, 22 | 125 | -5.30% |
| 31 Mar, 22 | 132 | 3.94% |
| 31 Dec, 21 | 127 | 9.48% |
| 30 Sep, 21 | 116 | -15.33% |
| 30 Jun, 21 | 137 | -4.20% |
| 31 Mar, 21 | 143 | -11.73% |
| 31 Dec, 20 | 162 | 11.72% |
| 30 Sep, 20 | 145 | 1.40% |
| 30 Jun, 20 | 143 | 72.29% |
| 31 Mar, 20 | 83 | 16.90% |
| 31 Dec, 19 | 71 | -6.58% |
| 30 Sep, 19 | 76 | -2.56% |
| 30 Jun, 19 | 78 | 21.88% |
| 31 Mar, 19 | 64 | 33.33% |
| 31 Dec, 18 | 48 | 4.35% |
| 30 Sep, 18 | 46 | -13.21% |
| 30 Jun, 18 | 53 | -7.02% |
| 31 Mar, 18 | 57 | 16.33% |
| 31 Dec, 17 | 49 | 16.67% |
| 30 Sep, 17 | 42 | 44.83% |
| 30 Jun, 17 | 29 | - |
As of 30 Jun 24, 124 institutions are holding Mersana Therapeutics's shares, representing a decrease of -3.13% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 114,181,798 | -2.82% |
| 31 Mar, 24 | 117,492,765 | 3.79% |
| 31 Dec, 23 | 113,199,475 | -0.47% |
| 30 Sep, 23 | 113,738,584 | 1.10% |
| 30 Jun, 23 | 112,502,473 | 5.52% |
| 31 Mar, 23 | 106,615,780 | 4.89% |
| 31 Dec, 22 | 101,642,740 | 10.23% |
| 30 Sep, 22 | 92,213,027 | 4.42% |
| 30 Jun, 22 | 88,308,356 | 8.89% |
| 31 Mar, 22 | 81,097,043 | 15.51% |
| 31 Dec, 21 | 70,205,444 | 2.12% |
| 30 Sep, 21 | 68,749,113 | -2.60% |
| 30 Jun, 21 | 70,583,373 | 0.72% |
| 31 Mar, 21 | 70,081,476 | 1.65% |
| 31 Dec, 20 | 68,942,610 | 0.34% |
| 30 Sep, 20 | 68,707,700 | 4.86% |
| 30 Jun, 20 | 65,524,022 | 63.32% |
| 31 Mar, 20 | 40,119,264 | 13.14% |
| 31 Dec, 19 | 35,459,391 | -7.85% |
| 30 Sep, 19 | 38,481,625 | -3.69% |
| 30 Jun, 19 | 39,956,308 | 8.44% |
| 31 Mar, 19 | 36,845,286 | 114.70% |
| 31 Dec, 18 | 17,160,931 | -13.40% |
| 30 Sep, 18 | 19,817,026 | 3.59% |
| 30 Jun, 18 | 19,130,992 | 2.15% |
| 31 Mar, 18 | 18,729,227 | 8.71% |
| 31 Dec, 17 | 17,229,249 | -1.37% |
| 30 Sep, 17 | 17,467,691 | 2.93% |
| 30 Jun, 17 | 16,970,149 | - |
Mersana Therapeutics (MRSN) has 114.18M shares outstanding as of 30 Jun 24, down -2.82% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 94.03% | 0.99% |
| 31 Mar, 24 | 97.41% | 1.10% |
| 31 Dec, 23 | 93.92% | 0.97% |
| 30 Sep, 23 | 98.38% | 0.90% |
| 30 Jun, 23 | 104.64% | 1.06% |
| 31 Mar, 23 | 99.16% | 0.84% |
| 31 Dec, 22 | 108.53% | 1.22% |
| 30 Sep, 22 | 94.44% | 1.11% |
| 30 Jun, 22 | 92.22% | 0.90% |
| 31 Mar, 22 | 101.46% | 1.03% |
| 31 Dec, 21 | 99.47% | 1.08% |
| 30 Sep, 21 | 95.81% | 0.93% |
| 30 Jun, 21 | 101.39% | 0.98% |
| 31 Mar, 21 | 101.59% | 0.81% |
| 31 Dec, 20 | 112.13% | 1.11% |
| 30 Sep, 20 | 100.42% | 0.86% |
| 30 Jun, 20 | 107.86% | 1.54% |
| 31 Mar, 20 | 83.60% | 1.26% |
| 31 Dec, 19 | 81.53% | 1.26% |
| 30 Sep, 19 | 80.45% | 1.15% |
| 30 Jun, 19 | 83.75% | 0.57% |
| 31 Mar, 19 | 121.60% | 2.22% |
| 31 Dec, 18 | 74.02% | 1.01% |
| 30 Sep, 18 | 85.60% | 1.23% |
| 30 Jun, 18 | 83.30% | 1.24% |
| 31 Mar, 18 | 82.09% | 1.44% |
| 31 Dec, 17 | 75.51% | 1.29% |
| 30 Sep, 17 | 76.56% | 1.38% |
| 30 Jun, 17 | 74.38% | - |
As of 30 Jun 24, Mersana Therapeutics is held by 94.03% institutional shareholders, representing a 0.99% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 63 | -12.50% |
| 31 Mar, 24 | 72 | 41.18% |
| 31 Dec, 23 | 51 | -16.39% |
| 30 Sep, 23 | 61 | -37.11% |
| 30 Jun, 23 | 97 | 29.33% |
| 31 Mar, 23 | 75 | -17.58% |
| 31 Dec, 22 | 91 | -10.78% |
| 30 Sep, 22 | 102 | 54.55% |
| 30 Jun, 22 | 66 | -5.71% |
| 31 Mar, 22 | 70 | -7.89% |
| 31 Dec, 21 | 76 | 33.33% |
| 30 Sep, 21 | 57 | -16.18% |
| 30 Jun, 21 | 68 | -10.53% |
| 31 Mar, 21 | 76 | -17.39% |
| 31 Dec, 20 | 92 | 16.46% |
| 30 Sep, 20 | 79 | -26.85% |
| 30 Jun, 20 | 108 | 86.21% |
| 31 Mar, 20 | 58 | 56.76% |
| 31 Dec, 19 | 37 | -5.13% |
| 30 Sep, 19 | 39 | -26.42% |
| 30 Jun, 19 | 53 | 15.22% |
| 31 Mar, 19 | 46 | 119.05% |
| 31 Dec, 18 | 21 | -12.50% |
| 30 Sep, 18 | 24 | -22.58% |
| 30 Jun, 18 | 31 | -27.91% |
| 31 Mar, 18 | 43 | 48.28% |
| 31 Dec, 17 | 29 | - |
| 30 Sep, 17 | 29 | - |
| 30 Jun, 17 | 29 | - |
63 institutional shareholders have increased their position in MRSN stock as of 30 Jun 24 compared to 72 in the previous quarter (a -12.50% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 36 | - |
| 31 Mar, 24 | 36 | 2.86% |
| 31 Dec, 23 | 35 | -20.45% |
| 30 Sep, 23 | 44 | 4.76% |
| 30 Jun, 23 | 42 | -8.70% |
| 31 Mar, 23 | 46 | 24.32% |
| 31 Dec, 22 | 37 | 37.04% |
| 30 Sep, 22 | 27 | -25.00% |
| 30 Jun, 22 | 36 | -7.69% |
| 31 Mar, 22 | 39 | 62.50% |
| 31 Dec, 21 | 24 | -29.41% |
| 30 Sep, 21 | 34 | -15.00% |
| 30 Jun, 21 | 40 | -13.04% |
| 31 Mar, 21 | 46 | - |
| 31 Dec, 20 | 46 | 15.00% |
| 30 Sep, 20 | 40 | 73.91% |
| 30 Jun, 20 | 23 | 64.29% |
| 31 Mar, 20 | 14 | -39.13% |
| 31 Dec, 19 | 23 | 4.55% |
| 30 Sep, 19 | 22 | 69.23% |
| 30 Jun, 19 | 13 | 44.44% |
| 31 Mar, 19 | 9 | -40.00% |
| 31 Dec, 18 | 15 | 87.50% |
| 30 Sep, 18 | 8 | -33.33% |
| 30 Jun, 18 | 12 | 33.33% |
| 31 Mar, 18 | 9 | -10.00% |
| 31 Dec, 17 | 10 | 42.86% |
| 30 Sep, 17 | 7 | - |
| 30 Jun, 17 | - | - |
36 institutional shareholders have reduced their position in MRSN stock as of 30 Jun 24 compared to 36 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 124 | -3.13% | 114,181,798 | -2.82% | 94.03% | 0.99% | 63 | -12.50% | 36 | - |
| 31 Mar, 24 | 128 | 17.43% | 117,492,765 | 3.79% | 97.41% | 1.10% | 72 | 41.18% | 36 | 2.86% |
| 31 Dec, 23 | 109 | -18.05% | 113,199,475 | -0.47% | 93.92% | 0.97% | 51 | -16.39% | 35 | -20.45% |
| 30 Sep, 23 | 133 | -24.00% | 113,738,584 | 1.10% | 98.38% | 0.90% | 61 | -37.11% | 44 | 4.76% |
| 30 Jun, 23 | 175 | 4.79% | 112,502,473 | 5.52% | 104.64% | 1.06% | 97 | 29.33% | 42 | -8.70% |
| 31 Mar, 23 | 167 | 6.37% | 106,615,780 | 4.89% | 99.16% | 0.84% | 75 | -17.58% | 46 | 24.32% |
| 31 Dec, 22 | 157 | 5.37% | 101,642,740 | 10.23% | 108.53% | 1.22% | 91 | -10.78% | 37 | 37.04% |
| 30 Sep, 22 | 149 | 19.20% | 92,213,027 | 4.42% | 94.44% | 1.11% | 102 | 54.55% | 27 | -25.00% |
| 30 Jun, 22 | 125 | -5.30% | 88,308,356 | 8.89% | 92.22% | 0.90% | 66 | -5.71% | 36 | -7.69% |
| 31 Mar, 22 | 132 | 3.94% | 81,097,043 | 15.51% | 101.46% | 1.03% | 70 | -7.89% | 39 | 62.50% |
| 31 Dec, 21 | 127 | 9.48% | 70,205,444 | 2.12% | 99.47% | 1.08% | 76 | 33.33% | 24 | -29.41% |
| 30 Sep, 21 | 116 | -15.33% | 68,749,113 | -2.60% | 95.81% | 0.93% | 57 | -16.18% | 34 | -15.00% |
| 30 Jun, 21 | 137 | -4.20% | 70,583,373 | 0.72% | 101.39% | 0.98% | 68 | -10.53% | 40 | -13.04% |
| 31 Mar, 21 | 143 | -11.73% | 70,081,476 | 1.65% | 101.59% | 0.81% | 76 | -17.39% | 46 | - |
| 31 Dec, 20 | 162 | 11.72% | 68,942,610 | 0.34% | 112.13% | 1.11% | 92 | 16.46% | 46 | 15.00% |
| 30 Sep, 20 | 145 | 1.40% | 68,707,700 | 4.86% | 100.42% | 0.86% | 79 | -26.85% | 40 | 73.91% |
| 30 Jun, 20 | 143 | 72.29% | 65,524,022 | 63.32% | 107.86% | 1.54% | 108 | 86.21% | 23 | 64.29% |
| 31 Mar, 20 | 83 | 16.90% | 40,119,264 | 13.14% | 83.60% | 1.26% | 58 | 56.76% | 14 | -39.13% |
| 31 Dec, 19 | 71 | -6.58% | 35,459,391 | -7.85% | 81.53% | 1.26% | 37 | -5.13% | 23 | 4.55% |
| 30 Sep, 19 | 76 | -2.56% | 38,481,625 | -3.69% | 80.45% | 1.15% | 39 | -26.42% | 22 | 69.23% |
| 30 Jun, 19 | 78 | 21.88% | 39,956,308 | 8.44% | 83.75% | 0.57% | 53 | 15.22% | 13 | 44.44% |
| 31 Mar, 19 | 64 | 33.33% | 36,845,286 | 114.70% | 121.60% | 2.22% | 46 | 119.05% | 9 | -40.00% |
| 31 Dec, 18 | 48 | 4.35% | 17,160,931 | -13.40% | 74.02% | 1.01% | 21 | -12.50% | 15 | 87.50% |
| 30 Sep, 18 | 46 | -13.21% | 19,817,026 | 3.59% | 85.60% | 1.23% | 24 | -22.58% | 8 | -33.33% |
| 30 Jun, 18 | 53 | -7.02% | 19,130,992 | 2.15% | 83.30% | 1.24% | 31 | -27.91% | 12 | 33.33% |
| 31 Mar, 18 | 57 | 16.33% | 18,729,227 | 8.71% | 82.09% | 1.44% | 43 | 48.28% | 9 | -10.00% |
| 31 Dec, 17 | 49 | 16.67% | 17,229,249 | -1.37% | 75.51% | 1.29% | 29 | - | 10 | 42.86% |
| 30 Sep, 17 | 42 | 44.83% | 17,467,691 | 2.93% | 76.56% | 1.38% | 29 | - | 7 | - |
| 30 Jun, 17 | 29 | - | 16,970,149 | - | 74.38% | - | 29 | - | - | - |
Mersana Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Mersana Therapeutics's stock was made by Protopapas Anna on Jan 17 2024, selling 29,399 shares at $2.71 per share (valued at $79.67K).
Mersana Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | - | - |
| Q2 2024 | 8 | - | - |
| Q1 2024 | 39 | 28 | 139.29% |
| Q4 2023 | 6 | 2 | 300.00% |
| Q3 2023 | 15 | 6 | 250.00% |
| Q2 2023 | 20 | 2 | 1000.00% |
| Q1 2023 | 29 | 22 | 131.82% |
| Q4 2022 | 3 | 4 | 75.00% |
| Q3 2022 | - | 2 | - |
| Q2 2022 | 29 | 2 | 1450.00% |
| Q1 2022 | 26 | 10 | 260.00% |
| Q4 2021 | 4 | 3 | 133.33% |
| Q3 2021 | 10 | 18 | 55.56% |
| Q2 2021 | 15 | 9 | 166.67% |
| Q1 2021 | 34 | 27 | 125.93% |
| Q4 2020 | 21 | 21 | 100.00% |
| Q3 2020 | 35 | 20 | 175.00% |
| Q2 2020 | 44 | 20 | 220.00% |
| Q1 2020 | 18 | - | - |
| Q3 2019 | 7 | 2 | 350.00% |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Mersana Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | 7 | - |
| Q4 2023 | - | 1 | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | 7 | - |
| Q4 2022 | - | 1 | - |
| Q3 2022 | - | 1 | - |
| Q2 2022 | 13 | 1 | 1300.00% |
| Q1 2022 | 1 | 2 | 50.00% |
| Q4 2021 | 2 | 1 | 200.00% |
| Q3 2021 | - | 10 | - |
| Q2 2021 | 1 | 3 | 33.33% |
| Q1 2021 | 3 | 5 | 60.00% |
| Q4 2020 | - | 6 | - |
| Q3 2020 | - | 4 | - |
| Q2 2020 | 6 | 6 | 100.00% |
| Q1 2020 | - | - | - |
| Q3 2019 | - | 1 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Mersana Therapeutics's stocks.
Mersana Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| PLRX | Pliant Therapeutics, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| RVMD | Revolution Medicines, Inc. |
| VRDN | Viridian Therapeutics, Inc. |
| MRUS | Merus N.V. |
| RCUS | Arcus Biosciences, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| REPL | Replimune Group, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| PTGX | Protagonist Therapeutics, Inc. |
| KURA | Kura Oncology, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
MRSN Ownership FAQ
Who Owns Mersana Therapeutics?
Mersana Therapeutics is owned by institutional shareholders (94.03%), insiders (1.35%), and public (4.61%). The largest institutional shareholder of Mersana Therapeutics is ECOR1 CAPITAL, LLC (15.95% of total shares) and the top mutual fund owner is HARTFORD HLS SERIES FUND II INC (1.62% of total shares).
Who are the major institutional shareholders of Mersana Therapeutics?
Mersana Therapeutics's major institutional shareholders are ECOR1 CAPITAL, LLC, VR ADVISER, LLC, NEXTECH INVEST LTD., BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC, and BLACKROCK INC.. The top five shareholders own together 47.16% of the company's share outstanding.
How many Mersana Therapeutics shareholders are there?
As of Jun 2024, there are 124 institutional shareholders of Mersana Therapeutics.
What percentage of Mersana Therapeutics is owned by ECOR1 CAPITAL, LLC?
ECOR1 CAPITAL, LLC owns 19.36M shares of Mersana Therapeutics, representing 15.95% of the company's total shares outstanding, valued at $38.92M (as of Jun 2024).
What percentage of Mersana Therapeutics is owned by VR ADVISER, LLC?
As of Jun 2024, VR ADVISER, LLC holds 11.33M shares of Mersana Therapeutics (MRSN), compromising 9.33% of the company, valued at $22.77M.
What percentage of Mersana Therapeutics is owned by NEXTECH INVEST LTD?
NEXTECH INVEST LTD is the third largest holder of Mersana Therapeutics. The company owns 9.53M of the company's shares outstanding (worth $19.15M).